Literature DB >> 15193406

In vivo uptake of an experimental microencapsulated diphtheria vaccine following sub-cutaneous immunisation.

Marisa Peyre1, Roland Fleck, David Hockley, Bruno Gander, Dorothea Sesardic.   

Abstract

Previous studies demonstrated in vitro phagocytosis of poly(lactide-co-glycolide) (PLGA) microspheres (MS) by macrophages and dendritic cells and the biodistribution of fluorescent PLGA particles following oral or intranasal administration. In this study, we report the uptake and biodistribution of sub-cutaneously administered fluorescent labelled PLGA MS loaded with diphtheria toxoid (DT). The cell type and percentage of fluorescent positive cells were determined by flow cytometry and confirmed by fluorescent microscopy. Fluorescent particles were detected inside cells of the peritoneal flush as early as 10 min post-inoculation, predominantly in cells of macrophage morphology. In vivo trafficking of PLGA particles following a sub-cutaneous immunisation of mice appeared to be governed by macrophages. However, in the first week after inoculation, dendritic cells played a significant role in the uptake and digestion of the microspheres, thereby triggering the immune response against the antigen. Fluorescent PLGA MS were also observed in cells of lymphoid tissues such as mesenteric lymph nodes (MLN) and spleen (S). However, microsphere fluorescence in lymphoid tissues decreased rapidly, as they were degraded inside the cells, thereby enabling the presentation of the antigen to specific cells of the immune system. To our knowledge, this is the first time the fate of immunogenic PLGA microspheres was studied in vivo following a sub-cutaneous injection route.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15193406     DOI: 10.1016/j.vaccine.2003.11.068

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  7 in total

1.  Poly(D,L-lactide-coglycolide) particles containing gentamicin: pharmacokinetics and pharmacodynamics in Brucella melitensis-infected mice.

Authors:  M C Lecaroz; M J Blanco-Prieto; M A Campanero; H Salman; C Gamazo
Journal:  Antimicrob Agents Chemother       Date:  2007-01-12       Impact factor: 5.191

2.  Alginate-chitosan-PLGA composite microspheres enabling single-shot hepatitis B vaccination.

Authors:  Xiaoling Zheng; Yongzhuo Huang; Caihong Zheng; Siyu Dong; Wenquan Liang
Journal:  AAPS J       Date:  2010-06-25       Impact factor: 4.009

Review 3.  Vaccine adjuvants: current challenges and future approaches.

Authors:  Jennifer H Wilson-Welder; Maria P Torres; Matt J Kipper; Surya K Mallapragada; Michael J Wannemuehler; Balaji Narasimhan
Journal:  J Pharm Sci       Date:  2009-04       Impact factor: 3.534

4.  Exploring the immunopotentiation of Chinese yam polysaccharide poly(lactic-co-glycolic acid) nanoparticles in an ovalbumin vaccine formulation in vivo.

Authors:  Li Luo; Tao Qin; Yifan Huang; Sisi Zheng; Ruonan Bo; Zhenguang Liu; Jie Xing; Yuanliang Hu; Jiaguo Liu; Deyun Wang
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

5.  Combining cationic liposomal delivery with MPL-TDM for cysteine protease cocktail vaccination against Leishmania donovani: evidence for antigen synergy and protection.

Authors:  Amrita Das; Nahid Ali
Journal:  PLoS Negl Trop Dis       Date:  2014-08-21

Review 6.  Harnessing Dendritic Cells for Poly (D,L-lactide-co-glycolide) Microspheres (PLGA MS)-Mediated Anti-tumor Therapy.

Authors:  Julia Koerner; Dennis Horvath; Marcus Groettrup
Journal:  Front Immunol       Date:  2019-04-05       Impact factor: 7.561

7.  Composite dissolving microneedles for coordinated control of antigen and adjuvant delivery kinetics in transcutaneous vaccination.

Authors:  Peter C Demuth; Wilfredo F Garcia-Beltran; Michelle Lim Ai-Ling; Paula T Hammond; Darrell J Irvine
Journal:  Adv Funct Mater       Date:  2013-01-14       Impact factor: 18.808

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.